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Abstract
Background:  A survey of Western Australia's general practitioners' (GPs') knowledge and
practices relating to genital chlamydia infection was conducted in mid-2005, prior to a multi-media
campaign which encouraged 15–24 year olds to seek chlamydia testing through their general
practitioner (GP). The survey aimed to raise GPs' awareness of chlamydia in preparation for the
campaign and to establish a baseline measure of their chlamydia-related knowledge and practices.
Methods: All 2038 GPs registered on the Australian Medical Publishing Company's database as
practising in Western Australia were sent a survey which covered clinical features of chlamydia,
investigations, treatment and public health issues; 576 (29%) responded.
Results: Most GPs were aware of chlamydia being common in the 20–24 year old age group, but
less than half were aware that it is common in 15–19 year olds. GPs missed many opportunities for
chlamydia testing in patients likely to be at risk of STIs, largely because they thought the patient
would be embarrassed. It is of concern that public health responsibilities in relation to chlamydia,
ie notification and contact tracing, were not undertaken by all GPs.
Conclusion: Australia is currently piloting chlamydia screening. For this to be successful, GPs will
need to maintain current knowledge and clinical suspicion about chlamydia, and be comfortable in
asking and receiving information about sexual behaviours. Only then will GPs have a significant
impact on curbing Australia's ever-increasing rates of chlamydia.
Background
In Western Australia (WA), as in other parts of Australia,
the occurrence of genital chlamydia infection (from now
on referred to as chlamydia) has been increasing, with
notifications and age-standardised rates almost quadru-
pling from 1591 to 5863 (82.6 to 284.6 per 100,000),
between 1997 and 2006 [1]. A recent study conducted in
Victoria, Australia, showed strong correlation between
chlamydia notification and testing rates in both men and
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women, suggesting that increased testing would identify
further chlamydia infections [2].
Left untreated, chlamydia can cause pelvic inflammatory
disease, ectopic pregnancy, infertility and chronic pelvic
pain [3]. Early diagnosis can be achieved through screen-
ing and has been shown to be of benefit in reducing such
complications [4,5]. Furthermore, access to nucleic acid
testing, self-collected or non-invasive sampling, and sin-
gle-dose treatment for chlamydia has been available since
the late 1990s, removing previous barriers to early detec-
tion and treatment.
Chlamydia occurs in most age groups, but is most com-
monly notified in those under 25 years. A recent preva-
lence study in family planning clinics in New South
Wales, Australia, found an overall prevalence of 5.6% in
16–25 year olds [6]; only slightly higher than the 5% prev-
alence found in over 500 18–24 year olds presenting to
GPs in Queensland, Australia [7]. While it is likely that
sexually transmissible infections (STIs) form a small part
of most Australian GPs' caseloads, in WA most cases of
chlamydia are diagnosed in general practice (Unpub-
lished data, WA Notifiable Infectious Disease Database,
Mak, personal communication, 2007.) GPs have reported
varying levels of commitment to chlamydia screening,
and a lack of willingness to screen opportunistically [8]. A
likely contributing factor is the fact that many GPs fail to
take a sufficiently detailed sexual history with which to
assess the patient's sexual health risk; this has been found
in many studies, both within Australia overseas, over the
last decade [9-13]. One recent Australian study found
GPs, particularly female GPs, were more likely to take a
sexual history if they perceived a patient to be in a high-
risk category, regardless of their actual risk behaviour [8].
A gender difference between GPs has been observed in
relation to chlamydia testing more generally, with female
GPs significantly more likely to offer testing than males
both in Australia and overseas [8,13,14].
In WA in 2004, 63% of chlamydia notifications were for
15–24 year olds [1]. In June 2005, the Department of
Health, Western Australia (DoH WA) launched a multi-
media campaign, Chlamydia: most people haven't got a clue,
encouraging young people aged 15–24 years to seek
chlamydia testing from their GP [15].
To ensure that they were adequately prepared to both
respond to increased requests for tests and to initiate dis-
cussion about chlamydia testing, GPs were surveyed
about their chlamydia knowledge and practices, and pro-
fessional development was offered to GPs who wished to
improve their skills in this area.
Methods
This study received approval from the LaTrobe University
Human Ethics Committee.
Six weeks before the campaign a survey was sent to all GPs
registered on the Australian Medical Publishing Com-
pany's database as practising in WA to:
• raise GP awareness of chlamydia
• to establish a baseline measure of GPs' chlamydia-
related knowledge and practices and
• to encourage GPs to reflect on their practice in relation
to STIs in general.
The 12 page, 32 item survey included items on the clinical
features of chlamydia, chlamydia-related investigations,
treatment and public health issues. GPs were encouraged
to participate through three "Fax Alerts" sent to each GP
by DoH WA. The first was sent just prior to the survey mail
out, the second approximately one week after the survey
would have been received, and the third one week before
the closing date for return of surveys.
Of the 2038 surveys mailed out, 21 were returned not
completed as the GP had resigned or semi-retired. A fur-
ther 16 GPs had left the practice or changed address. In all
576 GPs responded, a response rate of 29% (576/2001).
Twelve surveys returned after the closing date were
excluded as answers may have been biased by the cam-
paign. The final analysis included 564 surveys.
Gold Standard Answers to survey questions were mailed
to all GPs who completed the survey and to all GPs as part
of the Chlamydia: most people haven't got a clue promotional
package for health professionals (which also included an
order form for posters, pamphlets and guide to chlamydia
testing). GPs who chose not to complete the survey thus
still received educational material on chlamydia and sex-
ual health issues.
A comparison between the demographics of study partic-
ipants and a pool of over 2000 vocationally registered
Australian GPs suggested the participants of this study to
be slightly skewed to include more females, but to be rep-
resentative of age [16].
Results
Who completed the survey?
Marginally more male (51%) than female (48%) GPs
completed the survey (gender data was missing for 1%).
The majority of respondents were in the 35–54 year age
group (15% were less than 35 years, 31% were aged 34–
44 years, 29% were aged 45–54 years, 15% were aged 55–BMC Family Practice 2008, 9:17 http://www.biomedcentral.com/1471-2296/9/17
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64 years, and 11% were over 65 years). Almost 75% of
GPs responding to the survey practiced in urban areas.
Nearly two-thirds of respondents had been working in
general practice for 10–29 years (21% had worked for 0–
9 years, 34% for 10–19 years, 27% for 20–29 years, 12%
for 30–39 years and the remaining 5% for over 40 years).
About 50% of respondents stated that young people aged
15–24 years comprised 10–25% of their patient caseload
with a further 19% reporting that this age group com-
prised more than 25% of their patient caseload. Many GPs
who completed the survey performed sexual health con-
sultations such as offering contraceptive advice (56%
daily; 89% at least weekly) Pap smears (51% daily, 81% at
least weekly) and safe sex advice (30% daily; 72% at least
weekly). GP respondents diagnosed STIs regularly (21% at
least weekly; 66% at least monthly) and recommended
STI tests to asymptomatic 'at risk' patients (14% daily,
45% at least weekly and 70% at least monthly) on a regu-
lar basis.
Respondents reported diagnosing 266 cases of chlamydia
in the four weeks before receiving the survey. The almost
75% of the total number of respondents who practiced in
urban areas, diagnosed 72% of these cases.
Sexual risk assessment
When seeing patients whom they believed to be at risk of
STIs, 81% of GPs reported that they commonly or very
commonly asked about safe sex, 66% about having more
than one sex partner and 65% about injecting drug use.
However, fewer GPs asked about the important risk fac-
tors of overseas travel (54%) or sex with sex workers
(30%).
GPs were asked whether they would be likely to take or
update a sexual history in five different clinical situations.
Nearly all (96%) GPs would take a sexual history from a
man presenting as the sexual contact of an infected part-
ner, and around half would do so for a female patient
requesting a Pap smear. However, only 39% would do so
for a 24 year old woman routinely presenting for the con-
traceptive pill, and around a third would do so for a male
patient requesting overseas travel immunisation advice
(34%) or a young male with a new sexual partner (29%).
GPs were also asked how embarrassed a patient would be
if they took a sexual history in these situations. More than
two-thirds thought the young male sexual contact of an
infected partner (82%), and a young woman seeking a
Pap smear would not be embarrassed (79%). However,
over half of respondents believed a woman seeking a pre-
scription for the contraceptive pill (72%), a young man
with a new girlfriend (58%) and a man seeking overseas
travel immunisation advice (57%), would be embarrassed
or very embarrassed by the GP taking a sexual history.
There was a clear gender bias in terms of sexual risk assess-
ment with significantly fewer female than male GPs
believing that the female patients would be embarrassed
if they were to take or update a sexual history. Similarly
significantly fewer male than female GPs believed that the
male patients would be embarrassed if they were to take
or update a sexual history (Table 1). Despite this, female
GPs were generally more likely report that they would take
or update a sexual history (Table 2).
GPs were asked how they would rate the likelihood of
their recommending a chlamydia test in five different clin-
ical situations (Table 3). Most GPs (females, 96%; males
93%) reported that they would do so for the young male
presenting as the sexual contact of someone with a vaginal
infection. Female GPs were more likely than males to rec-
ommend chlamydia testing for the female patients
requesting contraception (37% vs. 14%, χ2 p < 0.001) and
a Pap smear (70% vs. 30%, χ2, p < 0.001), (Table 3). Dif-
ferences in responses depending on age and rural/urban
status were evident but minor in comparison to gender
differences.
For patients presenting with STI symptoms, most GPs
(87%) reported that they would commonly ask about a
previous STI history, 65% about injecting drug use, 67%
about recent overseas travel and 55% about specific sexual
practices.
Knowledge of age-groups in which chlamydia mostly is 
notified
Both nationally and in WA, chlamydia is most commonly
seen in the 15–19 year and the 20–24 year age-groups.
When asked which were the main age groups in which
Table 1: Percentage of GPs who believed that these patients would be embarrassed or very embarrassed if they were to take a sexual 
history, by gender of GP
Female n = 268 Male n = 284 χ2 p value
24 year old woman requires prescription for contraceptive pill 14.4 39.4 <0.001
24 year old woman for Pap smear test 11.1 30.1 <0.001
45 year old man requests travel immunisation advice 53.1 31.2 <0.001
32 year old man whose girlfriend has a vaginal infection 23.0 14.3 0.01
20 year old man for asthma medication prescription who also has new girlfriend 49.8 33.3 <0.001BMC Family Practice 2008, 9:17 http://www.biomedcentral.com/1471-2296/9/17
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chlamydia is most commonly seen, 76% of respondents
selected the older group, while less than half (45%)
selected the younger group. Almost 30% of respondents
selected the 25–29 year old age group, 4% selected the
30–34 year old age group, and 2% selected the 35–39 year
old age group. Less than 1% believed chlamydia occurred
most commonly at no particular age.
Public health responsibilities
Almost all GPs (99%) knew that chlamydia is a notifiable
infection in WA; however, only 85% stated that they
would always complete a notification form.
Contact tracing practices were variable, with less than
25% of respondents considering this to be always or
mostly their responsibility (Table 4). Slightly over half
(51%) of the participants sometimes considered contact
tracing to be their responsibility, whilst 21% believed this
never to be the case. In fact, in a patient in whom respond-
ents had diagnosed a laboratory confirmed STI, only 60%
would commonly ask details of sex partner for contact
tracing purposes.
Discussion and Conclusion
Information on the sexual health practices of the WA GP
workforce are not available, so it is impossible to deter-
mine how representative the survey respondents are of the
GPs in WA. Over half of the respondents were performing
Pap tests and providing contraceptive advice daily. This
suggests that GPs returning the survey had some interest
in reproductive health issues, and thus could reasonably
be expected to have a better than average knowledge of
sexual health.
It is likely that low STI caseloads were one reason for non-
response to the survey, as was found in a recent chlamy-
dia-related study of GPs in New South Wales with a 45%
response rate [17]. These findings also suggest that our
survey was returned by GPs with at least some interest in
sexual health.
Whilst the modest return rate of 29% is clearly a limita-
tion of the study, a recent postal survey of GPs in south-
eastern Australia, with a nearly 60% response rate,
reported very similar findings [18]. The response rate in
our study also holds a warning that non-responders may
have poorer chlamydia-related knowledge and practices
than respondents. This might not be of great concern if all
respondents had excellent knowledge and exemplary
practices. However, amongst responders to the survey,
most of whom are actively engaged in reproductive and
sexual health services, there are still many findings of con-
cern.
Foremost among these were GPs' practices in relation to
public health more generally. Whilst almost all GPs knew
that chlamydia was notifiable, some GPs stated that they
do not usually notify DoH WA of such infections. Less
Table 2: Percentage of GPs who are likely or very likely to take or update a sexual history, by gender of GP
Female n = 268 Male n = 284 χ2 p value
24 year old woman requires prescription for contraceptive pill 51.8 27.1 <0.001
24 year old woman for Pap smear test 71.6 39.0 <0.001
45 year old man requests travel immunisation advice 32.3 34.8 NS*
32 year old man whose girlfriend has a vaginal infection 97.3 94.0 0.05
20 year old man for asthma medication prescription who also has new girlfriend 32.0 25.7 NS*
* Not significant at 0.05 level
Table 3: Percentage of GPs who are likely or very likely to recommend testing for chlamydia by gender and age of GP
Female Male 25–34 years 35–44 years 45–54 years 55–64 years 65+ years
n = 268 n = 284 n = 61 n = 164 n = 187 n = 101 n = 44
24 year old woman requires prescription for 
contraceptive pill
36.9 14.4 29.5 29.8 24.0 24.7 9.0
24 year old woman for Pap smear test 70.1 30.3 67.2 58.5 46.5 38.6 31.8
45 year old man requests travel immunisation 
advice
8.5 10.5 11.4 6.7 9.0 10.8 13.6
32 year old man whose girlfriend has a vaginal 
infection
95.8 93.3 98.3 95.7 93.5 94.0 88.6
20 year old man for asthma medication 
prescription who also has new girlfriend
23.8 20.7 24.5 21.9 22.9 19.8 22.7BMC Family Practice 2008, 9:17 http://www.biomedcentral.com/1471-2296/9/17
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than 25% of GPs saw contact tracing as their responsibil-
ity, with a third not even usually asking a patient for
details about their sex partners for contact tracing pur-
poses. While general practice is not well structured for
contact tracing, this responsibility may benefit from sim-
ple innovative interventions, some of which are being
piloted as part of the pilot testing program for chlamydia.
These include contact tracing practice for practice nurses,
and a message on the laboratory result of positive chlamy-
dia tests providing the notifying doctor with a website
containing chlamydia treatment guidelines, client bro-
chure, and a printable letter for index cases to pass on to
exposed sexual partners [19].
Results of the study suggested that GPs may be missing
opportunities to assess the likelihood of chlamydia in
many of those most at risk. They thus need to maintain a
high level of clinical suspicion to consider a chlamydia
diagnosis. Even when GPs do initiate STI testing, many do
not ask all the questions necessary to ensure that appro-
priate STI tests are performed, eg. specific sexual practices
and injecting drug use which may indicate a greater likeli-
hood of BBVs.
Although GPs generally asked the most important ques-
tions of patients with an obvious STI risk, other opportu-
nities where sexual risk assessment could be easily
justified to the patient, such as during a Pap smear test and
in a consultation about contraception, were not as readily
taken up, particularly by male GPs. Yet Khan et al found
over half of the GPs in their study felt chlamydia testing
should be offered during a consultation at which a Pap
smear was taken [8].
Targeted screening for chlamydia requires considerable
communication skills [14]. A randomised controlled trial
comparing computer-assisted with face-to-face sexual his-
tory taking in a sexual health centre showed that women
reported significantly higher numbers of male partners in
the preceding 12 months when completing a computer
assisted self interview, suggesting that patients require a
non-judgemental environment to answer honestly ques-
tions about such sensitive issues [20]. A recent study
showing a positive association between chlamydia preva-
lence in young women and the numbers of male sexual
partners in the preceding year underscores the importance
of assessing the true numbers of sexual partners [21].
Given also that sexual history taking in general practice is
not commonly performed and frequently inadequate [9-
13], the challenge remains to ensure that neither asking
nor answering questions about sexual behaviour causes
embarrassment or shame for GPs or their patients.
With widespread availability of nucleic acid testing and
safe, effective single-dose treatment, chlamydia is an epi-
demic which should be addressed not just by opportunis-
tic case-finding but by a comprehensive population-based
control program. The effectiveness of screening for
chlamydia in asymptomatic young women has been
shown in studies of screening programs in Sweden and
the USA [22-25]. These countries have different health
care systems to Australia where most chlamydia is diag-
nosed in general practice. However a recent analysis of
annual opportunistic screening in women under 25 sug-
gested that chlamydia screening would be cost-effective in
Australia [26]. Such screening, based on age and ever-had-
sex that was appropriately advertised and funded would
overcome the discomfort and shame felt by many young
people about being asked about their sexual practices, and
by many GPs whose job it is to ask these questions.
If it is indeed true that the respondents to this survey rep-
resent the GPs who have some interest in sexual health
and/or a higher caseload of young people, then there is
much work ahead if all GPs are to be adequately trained
in best practice for chlamydia screening. GPs can make a
significant impact on chlamydia control through both
individual risk assessment and screening. However, it is
critical that GPs have the knowledge and skills to achieve
this. If three things can be achieved – current knowledge,
clinical suspicion, and comfort in asking about sexual
behaviours – we will be well on our way to gaining control
over the current chlamydia epidemic.
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